Add to Cart View Cart/Checkout More Products

Volume 3, 1999 CD

Six back issues of The International Journal of Pharmaceutical Compounding from 1999 on one convenient CD.
Only $95 per CD.
(Multiple Theme or Library CD orders priced at: 2 to 5 = $85; 6 to 9 = $75; 10 or more = $65 each.)

  • Permanant storage and easy retrieval of IJPC articles, formulations, SOP's and more.
  • Print IJPC articles in color for your marketing needs.

The back issues are stored as a high-resolution, full-color Adobe Portable Document Format (.pdf) file, complete with an electronic Table of Contents.

They may be searched by keyword and printed by the page. Software to read the PDF file is freely available from the Adobe Reader page.

Issues
Volume/IssueDateTitle
Vol. 3 No. 1 January/February 1999 Dental Compounding
Vol. 3 No. 2 March/April 1999 Compounding for Men's Health
Vol. 3 No. 3 May/June 1999 Compounding for Animals
Vol. 3 No. 4 July/August 1999 Compounding Parenteral Products
Vol. 3 No. 5 September/October 1999 Natural Hormone Replacement Therapy
Vol. 3 No. 6 November/December 1999 Compounding for Arthritis Patients

Articles
Volume/IssuePageTitle
Vol. 3 No. 1 4 Issues and Opportunities: Compounding for Dentistry
Vol. 3 No. 1 8 Compounding Mouthwashes and Rinses for Oral Ulcerations
Vol. 3 No. 1 10 Oral Ulceration Mouthwash
Vol. 3 No. 1 12 Mouthwash, Toothpaste and Toothgel Vehicles
Vol. 3 No. 1 12 Mouthwash/Gargle Formulation No. 1
Vol. 3 No. 1 12 Mouthwash/Gargle Formulation No. 2
Vol. 3 No. 1 12 Mouthwash/Gargle Formulation No. 3
Vol. 3 No. 1 13 Toothgel Vehicle
Vol. 3 No. 1 13 Toothpaste Vehicle
Vol. 3 No. 1 14 Toxicity of Amalgams
Vol. 3 No. 1 17 A Brief Look at the History of Oral Hygiene
Vol. 3 No. 1 18 Dental Compounding in Denmark
Vol. 3 No. 1 22 The Basics of Compounding: Compounding Ointments and Pastes
Vol. 3 No. 1 25 FDAMA Proposed List of Agents Not to be Compounded due to Withdrawal for Safety/Efficacy Concerns
Vol. 3 No. 1 30 Coenzyme Q10: It's Everywhere
Vol. 3 No. 1 32 Ubidicarenone (Coenzyme Q10) 200-mg Gelatin Troche
Vol. 3 No. 1 34 Case Reports: Steroid Substitute Treatment for Psoriasis; Metronidazole for Odor Related to Untreated Metastatic Breast Tumor
Vol. 3 No. 1 36 Audit Problems for Compounding Pharmacies
Vol. 3 No. 1 37 HRT Marketing Tip
Vol. 3 No. 1 38 Ringworms in Cats
Vol. 3 No. 1 39 Profile of a Practice
Vol. 3 No. 1 42 Dental Cavity Varnish
Vol. 3 No. 1 43 Dental Chemical Curettage Agent
Vol. 3 No. 1 44 Dental Pressure Indicating Paste (PIP)
Vol. 3 No. 1 45 Fluoride Lozenges
Vol. 3 No. 1 46 Gag Tablet
Vol. 3 No. 1 47 Gum Massage Gel
Vol. 3 No. 1 48 Misoprostol 0.0024% and Lidocaine 1% in Glycerin Mouth Paint
Vol. 3 No. 1 49 Misoprostol Mucoadhesive Anesthetic Powder
Vol. 3 No. 1 50 Potassium Nitrate Desensitizing Gel
Vol. 3 No. 1 51 Tetracycline 2.4% or Metronidazole 10% Periodontal Gel
Vol. 3 No. 1 52 Antioxidants, Featured Excipient:
Vol. 3 No. 1 56 Standard Operating Procedure for Performing Physical Quality Assessment of Suppositories, Troches, Lollipops and Sticks
Vol. 3 No. 1 58 Calculations
Vol. 3 No. 1 59 Stability of Four Commercial Products Delivered by Mail Order
Vol. 3 No. 1 64 Y-Site Stability of Fosphenytoin and Sodium Phenobarbital
Vol. 3 No. 1 67 Five-Day Stability of Vinorelbine in 5% Dextrose Injection and in 0.9% Sodium Chloride Injection at Room Temperature
Vol. 3 No. 2 76 Men's Health: Practical Solutions to a Profoundly Underrated Health-Care Crisis
Vol. 3 No. 2 80 Male Impotency and the Compounding Pharmacist
Vol. 3 No. 2 81 Medication Combinations for Penile Injections
Vol. 3 No. 2 85 Complementary Medical Approaches to Benign Prostatic Hyperplasia
Vol. 3 No. 2 88 Natural Testosterone: Hormone of the Heart
Vol. 3 No. 2 99 Use of Saw Palmetto and Pygeum in Men
Vol. 3 No. 2 101 Case Report: Testosterone Supplementation in a Vasectomy Patient
Vol. 3 No. 2 102 An Aftershave Lotion for Pseudofolliculitis Barbae
Vol. 3 No. 2 104 Compounding for Athletes: A Primer for Rookies
Vol. 3 No. 2 107 Book Reviews
Vol. 3 No. 2 109 Natural HRT: Corrective Measures When the System Goes Down
Vol. 3 No. 2 111 The Basics of Compounding: Compounding Creams and Lotions
Vol. 3 No. 2 116 Profile of a Practice
Vol. 3 No. 2 118 Tips for Collecting Mortars and Pestles
Vol. 3 No. 2 122 Personal Computing: Take Care When Choosing a Computer Consultant
Vol. 3 No. 2 126 Report: USP Expert Advisory Panel on Pharmacy Compounding Practices
Vol. 3 No. 2 127 Marketing Tip: Locator Maps
Vol. 3 No. 2 130 Athletic-Analgesic Rub
Vol. 3 No. 2 131 Dehydroepiandrosterone 50-mg Capsules
Vol. 3 No. 2 132 Minoxidil 3% and Finasteride 0.1% Topical Liquid
Vol. 3 No. 2 133 Piroxicam 0.5% in Pluronic Lecithin Organogel
Vol. 3 No. 2 134 Prostaglandin E1/Papaverine HCl/Phentolamine Mesylate Injection
Vol. 3 No. 2 135 Sildenafil Citrate 25-mg Sublingual Troches
Vol. 3 No. 2 136 Special Aftershave Preparations
Vol. 3 No. 2 137 Testosterone-Menthol Eutectic Ointment (2% Testosterone)
Vol. 3 No. 2 138 Testosterone 10-mg Troches
Vol. 3 No. 2 139 Testosterone 10-mg/0.1-mL Sublingual Drops
Vol. 3 No. 2 142 Preservatives, Featured Excipient:
Vol. 3 No. 2 145 Calculations
Vol. 3 No. 2 146 Standard Operating Procedure for Quality Assessment of Oral and Topical Liquids
Vol. 3 No. 2 148 Analysis of Extemporaneous Alprostadil Formulations
Vol. 3 No. 2 156 Stability of Extemporaneously Prepared Sterile Testosterone Solution in 0.9% Sodium Chloride Solution Large-Volume Parenterals in Plastic Bags
Vol. 3 No. 2 158 Quantitation of Testosterone Propionate in an Injection Using High Performance Liquid Chromatography
Vol. 3 No. 2 160 In Vitro Transdermal Delivery and Stability of Liposome-Encapsulated Prostaglandin E1
Vol. 3 No. 3 172 Compounding and the Specialty Veterinary Practice: An Interview with Gary Riggs, DVM, ABVP
Vol. 3 No. 3 176 Call of the Wild: Compounding for Zoos and Exotics
Vol. 3 No. 3 180 Improving Profitability with Veterinary Compounding
Vol. 3 No. 3 182 Compounding for Creatures: What Works
Vol. 3 No. 3 183 The Top Ten Veterinary Compound Preparations
Vol. 3 No. 3 186 Veterinary Flavor Suggestions
Vol. 3 No. 3 188 When is Compounding for Animals Legal?
Vol. 3 No. 3 193 Use of Fenbendazole in Treating Trichuriasis in Colobus Monkeys
Vol. 3 No. 3 194 Returning to our Roots
Vol. 3 No. 3 197 Value and Pricing: Figuring Out What You're Worth
Vol. 3 No. 3 199 Marketing Tip: Teachable Moments: A Simple Concept
Vol. 3 No. 3 200 The BPS Pharmacy Specialty Certification Program
Vol. 3 No. 3 206 Compounding for Athletes: Tips for Making the Team
Vol. 3 No. 3 209 The Basics of Compounding: Compounding Powder-Filled Capsules
Vol. 3 No. 3 215 Morphine Sulfate-Dextromethorphan Hydrobromide-Example of capsule with Dry Powder Fill
Vol. 3 No. 3 218 Amitriptyline HCl 1-mg/mL Oral Liquid and Gel
Vol. 3 No. 3 219 Buspirone HCl 2.5-mg/0.1-mL in PLO for Cats
Vol. 3 No. 3 220 General Sulfonamide 150-mg/mL Suspension
Vol. 3 No. 3 221 Nonaqueous Nonoleaginous Paste Base
Vol. 3 No. 3 222 Phenylpropanolamine HCl 10-mg Chewable Troches for Dogs
Vol. 3 No. 3 223 Progesterone 100-mg/mL Veterinary Injection
Vol. 3 No. 3 224 Sulfadiazine Sodium 333-mg/mL and Pyrimethamine 16.7-mg/mL Oral Liquid
Vol. 3 No. 3 225 Veterinary Antibiotic/Antifungal/Anti-Inflammatory Anesthetic Otic Drop
Vol. 3 No. 3 226 Veterinary Electrolyte Injection
Vol. 3 No. 3 227 Veterinary Phenobarbital 22-mg/mL Oral Liquid
Vol. 3 No. 3 228 Sweetening Agents, Featured Excipient:
Vol. 3 No. 3 232 Standard Operating Procedure for Quality Assessment of Powder-Filled, Hard-Gelatin Capsules
Vol. 3 No. 3 234 Calculations
Vol. 3 No. 3 235 Fosphenytoin Y-site Stability Studies with Lorazepam and Midazolam Hydrochloride
Vol. 3 No. 3 239 Quantitation of Testosterone in Suspension using High Performance Liquid Chromatography
Vol. 3 No. 3 241 Compatibility of Docetaxel with Selected Drugs during Simulated Y-Site Administration
Vol. 3 No. 4 253 Improving the Management, Operations and Cost Effectiveness of Sterile-Product Compounding
Vol. 3 No. 4 260 Green IV Nutritionals
Vol. 3 No. 4 263 Sterilization and Depyrogenation Principles and Methods
Vol. 3 No. 4 269 Book Review-The CIVAS Handbook
Vol. 3 No. 4 270 Sterile Product Compounding: A Comparison of ASHP and USP Guidelines
Vol. 3 No. 4 274 Extemporaneous Formulations in Pediatric Patients
Vol. 3 No. 4 277 Marketing Tip: PR Can Help with Image Change and Geographic Expansion
Vol. 3 No. 4 280 Antique Pharmaceutical Balances
Vol. 3 No. 4 285 Compounding for Athletes: Common Questions about Sports Medicine
Vol. 3 No. 4 288 Profile of a Practice
Vol. 3 No. 4 291 The Basics of Compounding: Compounding Special Capsules
Vol. 3 No. 4 294 Capsules with Liquid Fill-Sample-Progesterone 100-mg
Vol. 3 No. 4 294 Capsules with Semisolid Fill-Sample-Tri-Est
Vol. 3 No. 4 298 Calcium Levulinate 15-mg/mL Injection
Vol. 3 No. 4 299 Dextrose 20% and Sodium Chloride 20% Sclerosing Injection
Vol. 3 No. 4 300 Estradiol 5-mg/mL-in-Oil Injection
Vol. 3 No. 4 301 Fentanyl 20-mcg/mL and Bupivacaine HCl 1.25-mg/mL for Pump Administration
Vol. 3 No. 4 302 Morphine Sulfate 50-mg/mL Injection
Vol. 3 No. 4 303 Parenteral Admixture with Y-Site Administration
Vol. 3 No. 4 304 Tri-Est 2.5-mg/mL Aqueous Injection
Vol. 3 No. 4 305 Trimethoprim 50-mg/mL Injection
Vol. 3 No. 4 306 Vancomycin and Ceftazidime in Peritoneal Dialysis Solution
Vol. 3 No. 4 307 Veterinary Prochlorperazine and Isopropamide Injection
Vol. 3 No. 4 309 Acidifying Agents, Featured Excipient:
Vol. 3 No. 4 311 Calculations
Vol. 3 No. 4 312 Standard Operating Procedure for Quality Assessment of Special Hard-Gelatin Capsules
Vol. 3 No. 4 314 Quantitation of Testosterone-Cypionate-in-Oil Injection using High Performance Liquid Chromatography
Vol. 3 No. 4 316 Stability of Amphotericin B in 5% Dextrose Ophthalmic Solution
Vol. 3 No. 4 321 Rapid Pharmacokinetic Evaluation of Topical Drug Formulations
Vol. 3 No. 5 332 Interview: Katharina Dalton, MD: Progesterone and Related Topics
Vol. 3 No. 5 340 Finding the Balance
Vol. 3 No. 5 342 Top Ten HRT Compound Preparations
Vol. 3 No. 5 344 Wilson's Syndrome and T3 Therapy
Vol. 3 No. 5 350 Assessment and Management of Thermoregulation
Vol. 3 No. 5 352 Case Reports: Long-Term Effects of Topical Progesterone Cream Application; Progesterone Suppositories for PMS
Vol. 3 No. 5 355 Andropause: Annotated Citations from the Literature
Vol. 3 No. 5 357 Women's Health Book Reviews
Vol. 3 No. 5 360 Planning and Marketing a Natural HRT Patient Seminar
Vol. 3 No. 5 362 Marketing Tip: Collaboration Can Result in More Cost-Effective Seminars
Vol. 3 No. 5 364 Preventing Leakage in Oil-Filled Capsules
Vol. 3 No. 5 366 Feline Urologic Syndrome and Diet Formulation
Vol. 3 No. 5 368 Compounding Practice Structures
Vol. 3 No. 5 371 Closing in on 2000: Your Y2K Report
Vol. 3 No. 5 375 Chemical Facial Peel Formulations: an Overview
Vol. 3 No. 5 375 Jessner's Solution
Vol. 3 No. 5 375 Unna's Paste
Vol. 3 No. 5 376 Baker-Gordon Formula
Vol. 3 No. 5 380 Tamoxifen Citrate - A Potential Therapy for the Treatment of Keloids
Vol. 3 No. 5 381 Tamoxifen Citrate Cream 0.1%
Vol. 3 No. 5 382 Compounding for Athletes: Successful Sports Compounds
Vol. 3 No. 5 385 The Basics of Compounding: Compounding Gels
Vol. 3 No. 5 388 Lubricating Jelly Formula
Vol. 3 No. 5 388 Poloxamer Gel Base
Vol. 3 No. 5 388 Clear Carbomer Gel
Vol. 3 No. 5 389 Piroxicam 0.5% in an Alcoholic Gel
Vol. 3 No. 5 389 Methylcellulose Gels
Vol. 3 No. 5 389 Pluronic Lecithin Organogel (PLO Gel)
Vol. 3 No. 5 392 Estriol 0.2-mg/mL in Pluronic Lecithin Organogel
Vol. 3 No. 5 393 Ethinyl Estradiol 0.2-mg Gelatin Troches
Vol. 3 No. 5 394 Progesterone 50-mg/mL Topical Gel
Vol. 3 No. 5 395 Progesterone 100-mg/mL Sublingual Drops
Vol. 3 No. 5 396 Progesterone 100-mg Semisolid-Fill, Hard-Gelatin Capsules
Vol. 3 No. 5 397 Progesterone 10% Topical Cream
Vol. 3 No. 5 398 Progesterone 200-mg/mL in Pluronic Lecithin Organogel
Vol. 3 No. 5 399 Testosterone 1-mg Buccal Troches
Vol. 3 No. 5 400 Triple Estrogen 2.5-mg, Progesterone 100-mg and Testosterone 1-mg Capsules
Vol. 3 No. 5 401 Triple Estrogen 2.5-mg Slow-Release Capsules
Vol. 3 No. 5 404 Alkalizing Agents, Featured Excipient:
Vol. 3 No. 5 406 Standard Operating Procedure: Quality Assessment for Injectable Solutions
Vol. 3 No. 5 408 Calculations
Vol. 3 No. 5 409 In Vitro Studies on the Release of Morphine Sulfate from Compounded Slow-Release Morphine-Sulfate Capsules
Vol. 3 No. 5 412 Stability of Dobutamine Hydrochloride 4 mg/mL in 5% Dextrose Injection at 5 and 23 degrees C
Vol. 3 No. 5 415 Physical Compatibility of Calcium Acetate and Potassium Phosphates in Parenteral Nutrition Solutions Containing Aminosyn II
Vol. 3 No. 6 428 Glucosamine Sulfate: A Review of Efficacy for the Pharmacy Professional
Vol. 3 No. 6 433 Osteoarthritis: Other Options
Vol. 3 No. 6 438 Book Reviews: Maximizing the Arthritis Cure: A Step-by-Step Program To Faster, Stronger Healing During Any Stage of the Cure
Vol. 3 No. 6 438 Book Reviews: The Arthritis Cure: The Medical Miracle that Can Halt, Reverse, and May Even Cure Osteoarthritis
Vol. 3 No. 6 439 Electronically Controlled Drug Delivery
Vol. 3 No. 6 441 Case Reports for Arthritis Issue: Iontophoresis with Lidocaine and Dexamethasone for Treating Rotator Cuff Injury in a Hockey Player
Vol. 3 No. 6 441 Iontophoresis and Phonophoresis for Treating Epicondylitis
Vol. 3 No. 6 443 Compounding Radiolabeled Blood Cells for Diagnostic Imaging
Vol. 3 No. 6 447 Extemporaneous Formulations: How to Evaluate HPLC Stability Studies
Vol. 3 No. 6 454 Marketing Tip: Flavors: Target Marketing to Doctors and Patients
Vol. 3 No. 6 454 Book Reviews: Hatherleigh Guide to Psychopharmacology
Vol. 3 No. 6 454 Book Reviews: Medical Abbreviations: 14,000 Conveniences at the Expense of Communications and Safety
Vol. 3 No. 6 455 Profile of a Practice: Going the Extra Mile with Pharmaceutical Care
Vol. 3 No. 6 457 Independent Pharmacists Score High with Consumers
Vol. 3 No. 6 458 When Problem Audits Strike
Vol. 3 No. 6 461 The Basics of Compounding: Compounding Hard, Soft and Chewable Troches/Lozenges/Drops
Vol. 3 No. 6 462 Linguet Base (Soft Lozenge)
Vol. 3 No. 6 462 Sorbitol Based Hard Lozenges
Vol. 3 No. 6 462 Sucrose Based Hard Lozenges
Vol. 3 No. 6 463 Polyethylene Glycol (PEG) Troches (Soft Lozenges)
Vol. 3 No. 6 463 Polyethylene Glycol (PEG) Troches with Suspending Agent (Soft Lozenges)
Vol. 3 No. 6 464 Chewable Lozenges
Vol. 3 No. 6 468 Capsicum and Capsaicin Formulas
Vol. 3 No. 6 469 DMSO 70% Topical Solution
Vol. 3 No. 6 470 Glucosamine HCl 600-mg Capsules
Vol. 3 No. 6 471 Indomethacin 4% Topical Spray
Vol. 3 No. 6 472 Iontophoresis Solutions for Arthritis
Vol. 3 No. 6 473 Ketoprofen 2.5% in Pluronic Lecithin Organogel
Vol. 3 No. 6 474 Methotrexate 2.5-mg/5-mL Oral Liquid
Vol. 3 No. 6 475 Methyl Salicylate and Menthol Analgesic Stick
Vol. 3 No. 6 476 Piroxicam 1% Alcoholic Gel
Vol. 3 No. 6 477 Ultrasonic Preparations for Arthritis
Vol. 3 No. 6 479 Viscosity-Increasing Agents for Aqueous Systems, Featured Excipient:
Vol. 3 No. 6 487 Calculations
Vol. 3 No. 6 488 Operation of a Dry-Heat Sterilizing Oven and Validation of this Procedure
Vol. 3 No. 6 490 Calamine Lotion: Experimenting with a New Suspending Agent
Vol. 3 No. 6 493 Use of an Oxygen Extractor to Minimize Oxidation of Compounded Preparations
Vol. 3 No. 6 496 Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations